November 26, 2025 10:46 AM

UNAIDS Warns of Major Setbacks in Global HIV Response, Calls for Renewed Solidarity

The global response to HIV has suffered its most significant setback in decades, the Joint United Nations Programme on HIV/AIDS (UNAIDS) warned on Tuesday, calling for renewed solidarity, resilience, investment and innovation to achieve the goal of ending the AIDS epidemic. The warning comes in a new report titled “Overcoming Disruption, Transforming the AIDS Response,” which highlights the severe impact of declining international funding and weakened global solidarity on HIV prevention eff...

November 17, 2025 12:51 PM

Preventable cervical cancer kills a woman every two minutes: UN

One woman worldwide dies every two minutes due to cervical cancer -- a treatable and preventable disease --said the UN on Monday on the first official World Cervical Cancer Elimination Day. The day -- November 17 -- was designated by the Seventy-eighth World Health Assembly (WHA78.8) to raise awareness of the disease, and to expand access to HPV vaccination, high-performance screening, and treatment services. “Every two minutes, a woman dies from cervical cancer. Access to screening, vaccina...

April 14, 2025 3:59 PM

Explained: What is Type-5 diabetes? Why the malnutrition-induced condition is back?

While blood sugar cases are significantly soaring worldwide, a lesser-known malnutrition-related form of diabetes -- designated as Type-5 diabetes – is gaining global attention after decades. Nearly 75 years after being first recorded, the condition that previously remained undefined was designated as Type- 5 diabetes at the recently held International Diabetes Federation’s (IDF) World Diabetes Congress in Bangkok, Thailand. The condition, occurring often in young and thin adults, was firs...

December 17, 2024 10:00 PM

New HIV prevention drug could reach poorest countries by 2025, says health official

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start deliveries of Gilead Sciences’ lenacapavir on that timeline, said Hui Yang, head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria. However, she said a lot of things need to happen first, including the injectable drug receiving regulatory approvals from authorities like the U...